Early use of Delayed-Release Cysteamine in an infant under one year of age with nephropathic cystinosis (ERA 2026) - Apr 13, 2026 - Abstract #571; Pres time: Jun 4, 2026; 10:00 AM - 11:00 AM; Location: Research Zone; "Image Figure 1. Cysteamine dose (in plasma) and Cystine levels over time Legend: Cysteamine dose (in plasma) escalation (orange) is associated with a rapid decrease and subsequent stabilization of intracellular cystine levels (nmol hemicystine/mg protein)(green)."
Metabolic Disorders • Nephrology • Rare Diseases • Renal Disease
|
|
Luigi Annicchiarico Petruzzelli 1; Oriana De Marco 2; Ilaria Luongo 1; Vittorio Serio 1; Rosamunda D'arcangelo 1; Angela DE Luca 1; Paolo Giannattasio 1; Carmela Caputo 1; Daniela Molino 1; Martina Carucci 1; Barbara Brunetti 1; Gabriele Malgieri1
|